The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics

2Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

The EFOMP working group on the Role of Medical Physics Experts (MPEs) in Clinical Trials was established in 2010, with experts from across Europe and different areas of medical physics. Their main aims were: (1) To develop a consensus guidance document for the work MPEs do in clinical trials across Europe. (2) Complement the work by American colleagues in AAPM TG 113 and guidance from National Member Organisations. (3) To cover external beam radiotherapy, brachytherapy, nuclear medicine, molecular radiotherapy, and imaging. This document outlines the main output from this working group. Giving guidance to MPEs, and indeed all Medical Physicists (MP) and MP trainees wishing to work in clinical trials. It also gives guidance to the wider multidisciplinary team, advising where MPEs must legally be involved, as well as highlighting areas where MPEs skills and expertise can really add value to clinical trials.

Cite

CITATION STYLE

APA

Abbott, N. L., Chauvie, S., Marcu, L., DeJean, C., Melidis, C., Wientjes, R., … Hansen, C. R. (2024). The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics. Physica Medica, 126. https://doi.org/10.1016/j.ejmp.2024.104821

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free